Benefits of Reishi

Evidence-Based Benefits

• Immune modulation — a 2016 Cochrane review (Jin et al.) analyzed reishi as adjunctive therapy in cancer patients and found it increased CD3, CD4, and CD8 T-cell counts and NK cell activity across 5 RCTs
• Sleep and relaxation — Cui et al. (2012, n=48) found reishi extract (1.8g/day for 8 weeks) significantly improved subjective sleep quality and reduced fatigue in neurasthenia patients
• Anti-inflammatory activity — ganoderic acids inhibit NF-κB and COX-2 pathways, reducing inflammatory cytokine production (Cör et al., 2018 review)
• Hepatoprotective effects — preclinical and early clinical evidence shows reishi triterpenes protect liver cells from toxin-induced damage and reduce elevated liver enzymes
• Adjunctive cancer support — while NOT a cancer treatment, reishi may improve quality of life and immune parameters when used alongside conventional therapy (Jin et al., 2016)

What the Research Says

Reishi is a well-researched supplement known for its immune-modulating properties. A systematic review by Jin et al. (2016) analyzed five randomized controlled trials (RCTs) involving cancer patients and found that Reishi, when combined with chemotherapy or radiotherapy, improved immune cell counts compared to treatment alone. However, the evidence for tumor regression remains inconclusive due to insufficient data. Another notable study by Cui et al. (2012) demonstrated that Reishi extract significantly improved sleep duration and reduced fatigue in patients with neurasthenia.

Recent research has expanded on Reishi's potential benefits beyond immune modulation. A systematic review by Narayanan et al. (2023) evaluated 39 clinical studies involving mushroom preparations, including Reishi, and found that they may improve survival rates, immune responses, and quality of life in cancer patients. However, the authors noted that the evidence is limited by small sample sizes and a lack of large-scale randomized trials.

In terms of product quality, concerns have been raised about the composition of Reishi supplements. Many products contain mycelium grown on grain rather than the fruiting body, which may result in lower triterpene content—a key bioactive component. To address this, dual-extraction methods (combining hot water and alcohol) are recommended to ensure a comprehensive extraction of bioactive compounds.

Overall, Reishi shows promise as an adjunct therapy for immune support and symptom management in cancer patients, though further large-scale studies are needed to confirm its efficacy and optimize its use in clinical settings.

Related Conditions